Significant increase in volume has been observed in Indoco Remedies Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
INDOCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.1 pts less than Nifty Microcap 250 and 3.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
NSE noticed an unusual spike in trading volume in Indoco Remedies and has written to the company seeking an explanation, as is standard procedure when abnormal activity is detected. The company's reply is still pending, and no specific reason for the volume surge has been disclosed yet. Investors should wait for the company's response to understand whether there is any material information driving the activity. Until the company clarifies, the exact cause of the heightened volumes remains unknown.
This is a routine surveillance step and does not by itself indicate any wrongdoing or negative event. The stock may see volatility until the company responds; shareholders should monitor for any forthcoming disclosure that could explain the unusual trading interest.